ANVYL LLC has a total of 25 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are SERAGON PHARMACEUTICALS INC, HUTCHISON MEDIPHARMA ENTPR LTD and ARRAY BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Australia | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | India | 1 | |
#13 | Singapore | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Dasse Olivier | 19 |
#2 | Putman David | 10 |
#3 | Olivier Dasse | 3 |
#4 | Kanner Richard C | 2 |
#5 | David Putman | 1 |
#6 | Kanner Richard | 1 |
#7 | Putnam David | 1 |
Publication | Filing date | Title |
---|---|---|
CN107530323A | The deuterated analogue of Etifoxine, its derivative and their purposes | |
CN104334175A | Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof | |
EP2387575A1 | Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof |